Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 1997, 1203-1208, Vol 35, No. 5
AJ Johnson, N Karabatsos and RS Lanciotti
Colorado tick fever (CTF) virus elicits an acute illness in humans,
producing nonspecific flu-like symptoms and a biphasic fever in
approximately 50% of patients. The disease is transmitted by the adult
Rocky Mountain wood tick (Dermacentor andersoni), and therefore incidence
is limited by the habitat and life cycle of that vector. The early symptoms
of infection are difficult to distinguish from those of several other
agents, especially Rickettsia rickettsii. Serologic testing is usually
unable to provide evidence of CTF viral infection during the acute phase
because of the late appearance of the various antibodies. Here we report
the development and clinical application of a test to diagnose this disease
during the acute stages. Oligonucleotide primers to the S2 segment of CTF
(Florio) virus were made, and these were used in the amplification of a
528-bp fragment of DNA, transcribed from the double-stranded CTF virus RNA
template by reverse transcriptase PCR. RNAs processed from 16 CTF virus
isolates yielded similar results when analyzed on agarose gels. These were
distinguishable from their antigenic relatives Eyach, S6-14-03, and T5-
2092 and from other coltiviruses and an orbivirus but not from the
antigenically distinct CTF virus-related isolate 720896. A mouse model
demonstrated the utility of this method with whole-blood specimens, and CTF
virus was successfully detected in human sera from the initial day of the
onset of symptoms to 8 days later. The reverse transcriptase PCR method is
a promising tool for the early diagnosis of CTF viral infection, or for
ruling out CTF virus as the etiologic agent, in order to facilitate
appropriate medical support.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Detection of Colorado tick fever virus by using reverse transcriptase PCR and application of the technique in laboratory diagnosis [published erratum appears in J Clin Microbiol 1997 Jul;35(7):1920]
Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado 80522, USA. AJJ1@CDC.GOV
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|